Biomedical innovation alone is not sufficient to increase hepatitis C virus (HCV) treatment engagement among patients most marginalized, with sustainable resourcing of community services crucial in order to effect changes, a recent study found. This intervention from the HepCATT study comprised multiple components, including a nurse facilitator, peer support, and education initiatives. The 96 participants comprised drug service and intervention providers and clients with injecting history. Researchers found:
- Client engagement with a HCV treatment service rose from 16 at baseline in 2014 to 147 in 2016.
- Baseline testing and treatment barriers included limited HCV knowledge, fear of diagnosis and treatment, precarious living circumstances, and service-specific obstacles.
- Treatment engagement was aided by intervention timeliness, improved communication structures, personalized care, streamlined testing and treatment pathways, and peer support.
- The nurse practitioner was key to intervention success.
Harris M, Bonnington O, Harrison G, Hickman M, Irving W; on behalf of the HepCATT team. Understanding hepatitis C intervention success—Qualitative findings from the HepCATT study. [Published online ahead of print February 27, 2018]. J Viral Hepat. doi:10.1111/jvh.12869.
This Week's Must Reads
Screening for Syphilis Infection in Pregnant Women, JAMA; 2018 Sep 4; US Preventive Services Task Force
Treatment Intensification Guidelines for T2D , Ann Intern Med; ePub 2018 Sep 4; Roglic, et al
Immediate vs Gradual Nicotine Reduction in Cigarettes, JAMA; ePub 2018 Sep 4; Hatsukami, et al
Prevalence of Diabetes Among US Adults, BMJ; ePub 2018 Aug 27; Xu, Liu, et al
Effect of Fish Oil Supplementation in Pregnancy, BMJ; ePub 2018 Sep 4; Vinding, Stokholm, et al
Must Reads in Hepatitis
Treatment Uptake for HCV in VA Healthcare System, Clin Infect Dis; ePub 2018 Aug 22; Butt, et al
Prevalence of HCV Among Baby Boomers in US, J Infect Public Health; ePub 2018 Aug 28; Moore, et al
Universal Screening for Chronic HCV Infection, Clin Gastroenterol Hepatol; ePub 2018 Sep 7; Eckman, et al
Health-Related QOL in HIV/HCV Coinfected Patients, J Viral Hepat; ePub 2018 Aug 23; Saeed, et al
HCV Testing of PWID in High-Prevalence Settings, J Viral Hepat; ePub 2018 Jul 26; Scott, et al